Skip to main navigation Skip to search Skip to main content

Trans-eQTL mapping prioritises USP18 as a negative regulator of interferon response at a lupus risk locus

  • eQTLgen Consortium
  • , DIRECT Brown
  • , PRECISESADS Clinical Consortium
  • University of Tartu
  • Hinxton
  • University of Lausanne
  • Swiss Institute of Bioinformatics
  • University of Groningen
  • Oncode Institute
  • Wellcome Trust Sanger Institute
  • Universidad Nacional Autónoma de México
  • Pfizer
  • Bristol-Myers Squibb
  • GlaxoSmithKline
  • Pfizer/University of Granada/Andalusian Government Center for Genomics and Oncological Research (GENYO)
  • University of Granada
  • PTS
  • Karolinska Institutet
  • Newcastle University
  • University of Dundee
  • Georgia Institute of Technology
  • University of Exeter
  • University of North Carolina at Chapel Hill
  • German Centre for Cardiovascular Research
  • University of Greifswald
  • The University of Tokyo
  • The University of Osaka
  • RIKEN
  • University of Queensland
  • Erasmus University Rotterdam
  • Utrecht University
  • Leipzig University
  • The University of Chicago
  • Medical University of Białystok
  • Lee Kong Chian School of Medicine
  • Washington University St. Louis
  • German Center for Diabetes Research
  • Research Institute of the Santa Creu i Sant Pau Hospital
  • Centro de Investigación en Red de Enfermedades Raras (CIBERER)
  • Leiden University
  • National Institutes of Health
  • University of Turku
  • Tampere University
  • Vrije Universiteit Amsterdam

Research output: Contribution to journalArticlepeer-review

Abstract

Although genome-wide association studies have provided valuable insights into the genetic basis of complex traits and diseases, translating these findings to causal genes and their downstream mechanisms remains challenging. We performed trans expression quantitative trait locus (trans-eQTL) meta-analysis in 3734 lymphoblastoid cell line samples, identifying four robust loci that replicated in an independent multi-ethnic dataset of 682 individuals. The trans-eQTL signal at the ubiquitin specific peptidase 18 (USP18) locus colocalised with a GWAS signal for systemic lupus erythematosus (SLE). USP18 is a known negative regulator of interferon signalling and the SLE risk allele increased the expression of 50 interferon-inducible genes, suggesting that the risk allele impairs USP18’s ability to effectively limit the interferon response. Intriguingly, the USP18 trans-eQTL signal would not have been discovered in a meta-analysis of up to 43,301 whole blood samples, reaffirming the importance of capturing context-specific genetic effects for GWAS interpretation.

Original languageEnglish
Article number8795
JournalNature Communications
Volume16
Issue number1
DOIs
Publication statusPublished - Dec 2025

Fingerprint

Dive into the research topics of 'Trans-eQTL mapping prioritises USP18 as a negative regulator of interferon response at a lupus risk locus'. Together they form a unique fingerprint.

Cite this